Aether Bio is a developer of machine learning technology used to re-purpose enzymes in order to create a new compound.
Aether Bio has raised $15.0M in total funding. The most recent round was Venture - Series Unknown. The last funding was announced in December 2025.
Aether Bio's investors include Tribe Capital, Gaingels, SV Angel, Shrug Capital, 4DX Ventures.
Aether Bio is headquartered in Menlo Park, United States.
Aether Bio is a developer of machine learning technology used to re-purpose enzymes in order to create a new compound.
Aether Bio is at the Venture - Series Unknown stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Aether Bio — Funding & Investors." VCBacked, December 3, 2025, https://www.vcbacked.co/company/aether-bio. Accessed September 12, 2026.
VCBacked. (2025). Aether Bio — Funding & Investors. Retrieved September 12, 2026, from https://www.vcbacked.co/company/aether-bio
{{cite web |title=Aether Bio — Funding & Investors |url=https://www.vcbacked.co/company/aether-bio |website=VCBacked |access-date=September 12, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated